tiprankstipranks
Trending News
More News >
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
UK Market

SkinBioTherapeutics (SBTX) Income Statement

Compare
21 Followers

SkinBioTherapeutics Income Statement

Last quarter (Q4 2024), SkinBioTherapeutics's total revenue was £3.06M, an increase of 5459.30% from the same quarter last year. In Q4, SkinBioTherapeutics's net income was £337.85K. See SkinBioTherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 4.64M£ 1.21M£ 132.06K£ 74.76K£ 0.00
Gross Profit
£ 2.71M£ 683.04K£ 85.19K£ 45.34K£ -5.05K
Operating Expenses
£ 3.53M£ 3.59M£ 3.08M£ 3.03M£ 1.49M
Depreciation and Amortization
£ 426.60K£ 175.97K£ 44.19K£ 29.67K£ 5.05K
EBITDA
£ -196.54K£ -2.72M£ -2.96M£ -2.95M£ -1.49M
Operating Income
£ -826.79K£ -2.90M£ -3.00M£ -2.98M£ -1.49M
Other Income/Expenses
£ 111.67K£ -43.76K£ -8.89K£ -10.13K£ -3.68K
Pretax Income
£ -715.12K£ -2.95M£ -3.01M£ -2.99M£ -1.50M
Net Income
£ -696.25K£ -2.88M£ -2.84M£ -2.79M£ -1.43M
Per Share Metrics
Basic EPS
£ 0.00£ -0.02£ -0.02£ -0.02£ -0.01
Diluted EPS
£ 0.00£ -0.02£ -0.02£ -0.02£ -0.01
Weighted Average Shares Outstanding
227.87M 186.29M 164.71M 156.78M 146.70M
Weighted Average Shares Outstanding (Diluted)
227.87M 186.29M 164.71M 156.78M 146.70M
Currency in GBP

SkinBioTherapeutics Earnings and Revenue History